Absolute 0 8 0 8 B-clinical_variable
Neutrophil 9 19 9 19 I-clinical_variable
Count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1.5 34 37 34 37 B-lower_bound
x 38 39 38 39 I-lower_bound
10⁹/L 40 45 40 45 I-lower_bound

Adequate 0 8 46 54 O
renal 9 14 55 60 O
function 15 23 61 69 O
as 24 26 70 72 O
demonstrated 27 39 73 85 O
by 40 42 86 88 O
serum 43 48 89 94 B-clinical_variable
creatinine 49 59 95 105 I-clinical_variable
≤ 60 61 106 107 O
1.5 62 65 108 111 B-upper_bound
x 66 67 112 113 I-upper_bound
ULN 68 71 114 117 I-upper_bound
or 72 74 118 120 I-upper_bound
24 75 77 121 123 I-upper_bound
- 77 78 123 124 I-upper_bound
hour 78 82 124 128 I-upper_bound
urine 83 88 129 134 O
creatinine 89 99 135 145 B-clinical_variable
clearance 100 109 146 155 I-clinical_variable
calculation 110 121 156 167 I-clinical_variable
≥ 122 123 168 169 O
60 124 126 170 172 B-lower_bound
mL 127 129 173 175 I-lower_bound
/ 129 130 175 176 I-lower_bound
min 130 133 176 179 I-lower_bound

Allergy 0 7 180 187 O
or 8 10 188 190 O
sensitivity 11 22 191 202 O
to 23 25 203 205 O
irinotecan 26 36 206 216 B-allergy_name
or 37 39 217 219 O
cranberry 40 49 220 229 B-allergy_name
- 49 50 229 230 I-allergy_name
grape 50 55 230 235 I-allergy_name
juice 56 61 236 241 I-allergy_name
, 61 62 241 242 O
or 63 65 243 245 O
any 66 69 246 249 O
of 70 72 250 252 O
the 73 76 253 256 O
irinotecan 77 87 257 267 B-allergy_name
tablet 88 94 268 274 I-allergy_name
excipients 95 105 275 285 I-allergy_name

Are 0 3 286 289 O
currently 4 13 290 299 O
receiving 14 23 300 309 O
other 24 29 310 315 O
medications 30 41 316 327 B-treatment
intended 42 50 328 336 O
for 51 54 337 340 O
the 55 58 341 344 O
treatment 59 68 345 354 B-treatment
of 69 71 355 357 O
their 72 77 358 363 O
malignancy 78 88 364 374 B-cancer

Chronically 0 11 375 386 O
taking 12 18 387 393 O
an 19 21 394 396 O
oral 22 26 397 401 B-treatment
medication 27 37 402 412 I-treatment
known 38 43 413 418 O
to 44 46 419 421 O
be 47 49 422 424 O
a 50 51 425 426 O
P 52 53 427 428 O
- 53 54 428 429 O
gp 54 56 429 431 O
substrate 57 66 432 441 O
within 67 73 442 448 O
7 74 75 449 450 B-upper_bound
days 76 80 451 455 I-upper_bound
of 81 83 456 458 O
starting 84 92 459 467 O
treatment 93 102 468 477 B-treatment
with 103 107 478 482 I-treatment
Oratecan 108 116 483 491 I-treatment

Eastern 0 7 492 499 B-clinical_variable
Cooperative 8 19 500 511 I-clinical_variable
Oncology 20 28 512 520 I-clinical_variable
Group 29 34 521 526 I-clinical_variable
performance 35 46 527 538 I-clinical_variable
status 47 53 539 545 I-clinical_variable
of 54 56 546 548 O
0 57 58 549 550 B-lower_bound
to 59 61 551 553 O
1 62 63 554 555 B-upper_bound

Have 0 4 556 560 O
not 5 8 561 564 O
recovered 9 18 565 574 O
to 19 21 575 577 O
≤ 22 23 578 579 O
Grade 24 29 580 585 B-upper_bound
1 30 31 586 587 I-upper_bound
toxicity 32 40 588 596 O
from 41 45 597 601 O
previous 46 54 602 610 B-treatment
anticancer 55 65 611 621 I-treatment
treatments 66 76 622 632 I-treatment
or 77 79 633 635 O
previous 80 88 636 644 O
IPs 89 92 645 648 O

Hemoglobin 0 10 649 659 B-clinical_variable
≥ 11 12 660 661 O
9 13 14 662 663 B-lower_bound
g 15 16 664 665 I-lower_bound
/ 16 17 665 666 I-lower_bound
L 17 18 666 667 I-lower_bound

Histologically 0 14 668 682 O
or 15 17 683 685 O
cytologically 18 31 686 699 O
confirmed 32 41 700 709 O
solid 42 47 710 715 B-cancer
tumor 48 53 716 721 I-cancer
that 54 58 722 726 O
is 59 61 727 729 O
metastatic 62 72 730 740 B-cancer
or 73 75 741 743 O
unresectable 76 88 744 756 O
and 89 92 757 760 O
for 93 96 761 764 O
which 97 102 765 770 O
standard 103 111 771 779 O
curative 112 120 780 788 O
or 121 123 789 791 O
palliative 124 134 792 802 O
measures 135 143 803 811 O
do 144 146 812 814 O
not 147 150 815 818 O
exist 151 156 819 824 O
or 157 159 825 827 O
are 160 163 828 831 O
no 164 166 832 834 O
longer 167 173 835 841 O
effective 174 183 842 851 O

Life 0 4 852 856 B-clinical_variable
expectancy 5 15 857 867 I-clinical_variable
of 16 18 868 870 O
at 19 21 871 873 O
least 22 27 874 879 O
3 28 29 880 881 B-lower_bound
months 30 36 882 888 I-lower_bound

Major 0 5 889 894 B-treatment
surgery 6 13 895 902 I-treatment
to 14 16 903 905 O
the 17 20 906 909 O
upper 21 26 910 915 B-treatment
gastrointestinal 27 43 916 932 I-treatment
( 44 45 933 934 I-treatment
GI 45 47 934 936 I-treatment
) 47 48 936 937 I-treatment
tract 49 54 938 943 I-treatment
, 54 55 943 944 O
or 56 58 945 947 O
have 59 63 948 952 O
a 64 65 953 954 O
history 66 73 955 962 O
of 74 76 963 965 O
GI 77 79 966 968 B-chronic_disease
disease 80 87 969 976 I-chronic_disease
or 88 90 977 979 O
other 91 96 980 985 O
medical 97 104 986 993 B-chronic_disease
condition 105 114 994 1003 I-chronic_disease
that 115 119 1004 1008 O
, 119 120 1008 1009 O
in 121 123 1010 1012 O
the 124 127 1013 1016 O
opinion 128 135 1017 1024 O
of 136 138 1025 1027 O
the 139 142 1028 1031 O
investigator 143 155 1032 1044 O
may 156 159 1045 1048 O
interfere 160 169 1049 1058 O
with 170 174 1059 1063 O
oral 175 179 1064 1068 B-treatment
drug 180 184 1069 1073 I-treatment
absorption 185 195 1074 1084 I-treatment

Measurable 0 10 1085 1095 B-chronic_disease
disease 11 18 1096 1103 I-chronic_disease
as 19 21 1104 1106 O
per 22 25 1107 1110 O
Response 26 34 1111 1119 O
Evaluation 35 45 1120 1130 O
Criteria 46 54 1131 1139 O
in 55 57 1140 1142 O
Solid 58 63 1143 1148 O
Tumors 64 70 1149 1155 O
( 71 72 1156 1157 O
RECIST 72 78 1157 1163 O
) 78 79 1163 1164 O
Version 80 87 1165 1172 O
1.1 88 91 1173 1176 O
criteria 92 100 1177 1185 O

Platelet 0 8 1186 1194 B-clinical_variable
count 9 14 1195 1200 I-clinical_variable
≥ 15 16 1201 1202 O
100 17 20 1203 1206 B-lower_bound
x 21 22 1207 1208 I-lower_bound
10⁹/L 23 28 1209 1214 I-lower_bound

Received 0 8 1215 1223 O
IPs 9 12 1224 1227 B-clinical_variable
within 13 19 1228 1234 O
14 20 22 1235 1237 B-upper_bound
days 23 27 1238 1242 I-upper_bound
or 28 30 1243 1245 O
5 31 32 1246 1247 B-lower_bound
half 33 37 1248 1252 I-lower_bound
- 37 38 1252 1253 I-lower_bound
lives 38 43 1253 1258 I-lower_bound
of 44 46 1259 1261 O
the 47 50 1262 1265 O
first 51 56 1266 1271 O
study 57 62 1272 1277 O
dosing 63 69 1278 1284 O
day 70 73 1285 1288 O
, 73 74 1288 1289 O
whichever 75 84 1290 1299 O
is 85 87 1300 1302 O
longer 88 94 1303 1309 O

Require 0 7 1310 1317 O
therapeutic 8 19 1318 1329 O
use 20 23 1330 1333 O
of 24 26 1334 1336 O
anticoagulation 27 42 1337 1352 B-treatment
medications 43 54 1353 1364 I-treatment

Sexually 0 8 1365 1373 O
active 9 15 1374 1380 O
male 16 20 1381 1385 B-gender
subjects 21 29 1386 1394 I-gender
must 30 34 1395 1399 O
use 35 38 1400 1403 B-contraception_consent
a 39 40 1404 1405 I-contraception_consent
barrier 41 48 1406 1413 I-contraception_consent
method 49 55 1414 1420 I-contraception_consent
of 56 58 1421 1423 I-contraception_consent
contraception 59 72 1424 1437 I-contraception_consent
during 73 79 1438 1444 O
the 80 83 1445 1448 O
study 84 89 1449 1454 O
and 90 93 1455 1458 O
agree 94 99 1459 1464 B-contraception_consent
to 100 102 1465 1467 I-contraception_consent
continue 103 111 1468 1476 I-contraception_consent
the 112 115 1477 1480 I-contraception_consent
use 116 119 1481 1484 I-contraception_consent
of 120 122 1485 1487 I-contraception_consent
male 123 127 1488 1492 I-contraception_consent
contraception 128 141 1493 1506 I-contraception_consent
for 142 145 1507 1510 O
at 146 148 1511 1513 O
least 149 154 1514 1519 O
30 155 157 1520 1522 B-lower_bound
days 158 162 1523 1527 I-lower_bound
after 163 168 1528 1533 O
the 169 172 1534 1537 O
last 173 177 1538 1542 O
dose 178 182 1543 1547 O
of 183 185 1548 1550 O
IP 186 188 1551 1553 B-treatment

Taking 0 6 1554 1560 O
a 7 8 1561 1562 O
medication 9 19 1563 1573 B-treatment
known 20 25 1574 1579 O
to 26 28 1580 1582 O
be 29 31 1583 1585 O
a 32 33 1586 1587 O
clinically 34 44 1588 1598 O
significant 45 56 1599 1610 O
cytochrome 57 67 1611 1621 B-treatment
( 68 69 1622 1623 I-treatment
CYP 69 72 1623 1626 I-treatment
) 72 73 1626 1627 I-treatment
3A4 74 77 1628 1631 I-treatment
strong 78 84 1632 1638 I-treatment
inhibitor 85 94 1639 1648 I-treatment
( 95 96 1649 1650 O
eg 96 98 1650 1652 O
, 98 99 1652 1653 O
ketoconazole 100 112 1654 1666 B-treatment
within 113 119 1667 1673 O
14 120 122 1674 1676 B-upper_bound
days 123 127 1677 1681 I-upper_bound
) 127 128 1681 1682 O
or 129 131 1683 1685 O
strong 132 138 1686 1692 O
inducers 139 147 1693 1701 O
( 148 149 1702 1703 O
eg 149 151 1703 1705 O
, 151 152 1705 1706 O
rifampin 153 161 1707 1715 B-treatment
and 162 165 1716 1719 O
St. 166 169 1720 1723 B-treatment
John 170 174 1724 1728 I-treatment
's 174 176 1728 1730 I-treatment
Wort 177 181 1731 1735 I-treatment
within 182 188 1736 1742 O
14 189 191 1743 1745 O
days 192 196 1746 1750 O
) 196 197 1750 1751 O
of 198 200 1752 1754 O
starting 201 209 1755 1763 O
treatment 210 219 1764 1773 B-treatment
with 220 224 1774 1778 I-treatment
Oratecan 225 233 1779 1787 I-treatment

Taking 0 6 1788 1794 O
a 7 8 1795 1796 O
medication 9 19 1797 1807 O
known 20 25 1808 1813 O
to 26 28 1814 1816 O
be 29 31 1817 1819 O
clinically 32 42 1820 1830 O
significant 43 54 1831 1842 O
P 55 56 1843 1844 B-treatment
- 56 57 1844 1845 I-treatment
gp 57 59 1845 1847 I-treatment
inhibitors 60 70 1848 1858 I-treatment
or 71 73 1859 1861 I-treatment
inducers 74 82 1862 1870 I-treatment
within 83 89 1871 1877 O
14 90 92 1878 1880 B-upper_bound
days 93 97 1881 1885 I-upper_bound
of 98 100 1886 1888 O
treatment 101 110 1889 1898 B-treatment
with 111 115 1899 1903 I-treatment
Oratecan 116 124 1904 1912 I-treatment

Total 0 5 1913 1918 B-clinical_variable
bilirubin 6 15 1919 1928 I-clinical_variable
of 16 18 1929 1931 O
≤ 19 20 1932 1933 O
1.5 21 24 1934 1937 B-upper_bound
mg 25 27 1938 1940 I-upper_bound
/ 27 28 1940 1941 I-upper_bound
dL 28 30 1941 1943 I-upper_bound
or 31 33 1944 1946 O
≤ 34 35 1947 1948 O
2.0 36 39 1949 1952 B-upper_bound
mg 40 42 1953 1955 I-upper_bound
/ 42 43 1955 1956 I-upper_bound
dL 43 45 1956 1958 I-upper_bound
for 46 49 1959 1962 O
subjects 50 58 1963 1971 O
with 59 63 1972 1976 O
liver 64 69 1977 1982 B-cancer
metastasis 70 80 1983 1993 I-cancer

Uncontrolled 0 12 1994 2006 O
intercurrent 13 25 2007 2019 O
illness 26 33 2020 2027 O
including 34 43 2028 2037 O
, 43 44 2037 2038 O
but 45 48 2039 2042 O
not 49 52 2043 2046 O
limited 53 60 2047 2054 O
to 61 63 2055 2057 O
, 63 64 2057 2058 O
ongoing 65 72 2059 2066 O
or 73 75 2067 2069 O
active 76 82 2070 2076 B-chronic_disease
infection 83 92 2077 2086 I-chronic_disease
, 92 93 2086 2087 O
symptomatic 94 105 2088 2099 O
congestive 106 116 2100 2110 B-chronic_disease
heart 117 122 2111 2116 I-chronic_disease
failure 123 130 2117 2124 I-chronic_disease
, 130 131 2124 2125 O
myocardial 132 142 2126 2136 B-chronic_disease
infarction 143 153 2137 2147 I-chronic_disease
within 154 160 2148 2154 O
the 161 164 2155 2158 O
last 165 169 2159 2163 B-upper_bound
6 170 171 2164 2165 I-upper_bound
months 172 178 2166 2172 I-upper_bound
, 178 179 2172 2173 O
unstable 180 188 2174 2182 B-chronic_disease
angina 189 195 2183 2189 I-chronic_disease
pectoris 196 204 2190 2198 I-chronic_disease
, 204 205 2198 2199 O
cardiac 206 213 2200 2207 B-chronic_disease
arrhythmia 214 224 2208 2218 I-chronic_disease
, 224 225 2218 2219 O
chronic 226 233 2220 2227 B-chronic_disease
pulmonary 234 243 2228 2237 I-chronic_disease
disease 244 251 2238 2245 I-chronic_disease
requiring 252 261 2246 2255 O
oxygen 262 268 2256 2262 O
, 268 269 2262 2263 O
known 270 275 2264 2269 O
bleeding 276 284 2270 2278 B-chronic_disease
disorders 285 294 2279 2288 I-chronic_disease
, 294 295 2288 2289 O
or 296 298 2290 2292 O
any 299 302 2293 2296 O
concomitant 303 314 2297 2308 O
illness 315 322 2309 2316 O
or 323 325 2317 2319 O
social 326 332 2320 2326 O
situation 333 342 2327 2336 O
that 343 347 2337 2341 O
would 348 353 2342 2347 O
limit 354 359 2348 2353 O
compliance 360 370 2354 2364 O
with 371 375 2365 2369 O
study 376 381 2370 2375 O
requirements 382 394 2376 2388 O

Woman 0 5 2389 2394 B-gender
must 6 10 2395 2399 O
be 11 13 2400 2402 O
postmenopausal 14 28 2403 2417 O
( 29 30 2418 2419 O
> 30 31 2419 2420 O
12 32 34 2421 2423 B-lower_bound
months 35 41 2424 2430 I-lower_bound
without 42 49 2431 2438 O
menses 50 56 2439 2445 O
) 56 57 2445 2446 O
or 58 60 2447 2449 O
surgically 61 71 2450 2460 B-treatment
sterile 72 79 2461 2468 I-treatment
( 80 81 2469 2470 O
ie 81 83 2470 2472 O
, 83 84 2472 2473 O
by 85 87 2474 2476 O
hysterectomy 88 100 2477 2489 B-treatment
and/or 101 107 2490 2496 O
bilateral 108 117 2497 2506 B-treatment
oophorectomy 118 130 2507 2519 I-treatment
) 130 131 2519 2520 O
or 132 134 2521 2523 O
must 135 139 2524 2528 O
be 140 142 2529 2531 O
using 143 148 2532 2537 B-contraception_consent
effective 149 158 2538 2547 I-contraception_consent
contraception 159 172 2548 2561 I-contraception_consent
( 173 174 2562 2563 O
ie 174 176 2563 2565 O
, 176 177 2565 2566 O
oral 178 182 2567 2571 O
contraceptives 183 197 2572 2586 O
, 197 198 2586 2587 O
intrauterine 199 211 2588 2600 O
device 212 218 2601 2607 O
, 218 219 2607 2608 O
double 220 226 2609 2615 O
barrier 227 234 2616 2623 O
method 235 241 2624 2630 O
of 242 244 2631 2633 O
condom 245 251 2634 2640 O
and 252 255 2641 2644 O
spermicide 256 266 2645 2655 O
) 266 267 2655 2656 O
and 268 271 2657 2660 O
agree 272 277 2661 2666 B-contraception_consent
to 278 280 2667 2669 I-contraception_consent
continue 281 289 2670 2678 I-contraception_consent
use 290 293 2679 2682 I-contraception_consent
of 294 296 2683 2685 I-contraception_consent
contraception 297 310 2686 2699 I-contraception_consent
for 311 314 2700 2703 O
30 315 317 2704 2706 B-upper_bound
days 318 322 2707 2711 I-upper_bound
after 323 328 2712 2717 I-upper_bound
their 329 334 2718 2723 O
last 335 339 2724 2728 O
dose 340 344 2729 2733 O
of 345 347 2734 2736 O
IP 348 350 2737 2739 O

Women 0 5 2740 2745 B-gender
who 6 9 2746 2749 O
are 10 13 2750 2753 O
pregnant 14 22 2754 2762 B-pregnancy

≥ 0 1 2763 2764 O
18 2 4 2765 2767 B-lower_bound
years 5 10 2768 2773 I-lower_bound
of 11 13 2774 2776 O
age 14 17 2777 2780 B-age

